Denna sida på svenska

Christian G. Giske

Senior lecturer/senior physician

Visiting address : Alfred Nobels Allé 8, Plan 7, Karolinska Universitetssjukhuset, Huddinge 141 86 Stockholm, Sweden
Postal address : Department of Laboratory Medicine (LABMED), H5, Division of Clinical Microbiology, F68, Karolinska Universitetssjukhuset, Huddinge 141 86 Stockholm, Sweden
Delivery address : F68, Karolinska Universitetssjukhuset, Huddinge 141 86 Stockholm, Sweden

Publications

Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study
Ny S, Löfmark S, Börjesson S, Englund S, Ringman M, Bergström J, et al
The Journal of antimicrobial chemotherapy 2017;72(2):582-588

Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
Grundmann H, Glasner C, Albiger B, Aanensen Dm, Tomlinson Ct, Andrasević At, et al
The Lancet. Infectious diseases 2017;17(2):153-163

Rapid EUCAST disc diffusion testing of MDR Escherichia coli and Klebsiella pneumoniae: inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation
Fröding I, Vondracek M, Giske Cg
The Journal of antimicrobial chemotherapy 2017;72(4):1094-1102

The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
Ellington Mj, Ekelund O, Aarestrup Fm, Canton R, Doumith M, Giske C, et al
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2017;23(1):2-22

14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality
Holmbom M, Giske Cg, Fredrikson M, Östholm Balkhed Å, Claesson C, Nilsson Le, et al
PloS one 2016;11(11):e0166527-

A randomized controlled study of 5 and 10 days treatment with phenoxymethylpenicillin for pharyngotonsillitis caused by streptococcus group A - a protocol study
Skoog G, Edlund C, Giske Cg, Mölstad S, Norman C, Sundvall Pd, et al
BMC infectious diseases 2016;16():484-

A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp
Kabir Mh, Meunier D, Hopkins Kl, Giske Cg, Woodford N
The Journal of antimicrobial chemotherapy 2016;71(5):1213-6

Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study
Kjellander C, Björkholm M, Källman O, Giske Cg, Weibull Ce, Löve Tj, et al
Annals of hematology 2016;95(6):871-9

Escherichia coli: an old friend with new tidings
Vila J, Saez-lopez E, Johnson Jr, Romling U, Dobrindt U, Canton R, et al
FEMS MICROBIOLOGY REVIEWS 2016;40(4):437-463

Etiology of bone and joint infections: a case series of 363 consecutive patients from an orthopaedic infection unit
Wallander K, Jorup-rönström C, Ullberg M, Törnblom I, Ottosson C, Giske Cg
Infectious diseases (London, England) 2016;48(8):618-25

Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in vitro time-kill experiments
Lagerbäck P, Khine Ww, Giske Cg, Tängdén T
The Journal of antimicrobial chemotherapy 2016;71(8):2321-5

Frequent acquisition of low-virulence strains of ESBL-producing Escherichia coli in travellers
Vading M, Kabir Mh, Kalin M, Iversen A, Wiklund S, Nauclér P, et al
The Journal of antimicrobial chemotherapy 2016;71(12):3548-3555

Metagenomic analysis of bloodstream infections in patients with acute leukemia and therapy-induced neutropenia
Gyarmati P, Kjellander C, Aust C, Song Y, Öhrmalm L, Giske Cg
Scientific reports 2016;6():23532-

Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients
Petersson J, Giske Cg, Eliasson E
Acta anaesthesiologica Scandinavica 2016;60(10):1425-1436

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB
Niward K, Ängeby K, Chryssanthou E, Paues J, Bruchfeld J, Jureen P, et al
The Journal of antimicrobial chemotherapy 2016;71(2):333-8

The IRIDICA PCR/Electrospray Ionization-Mass Spectrometry Assay on Bronchoalveolar Lavage for Bacterial Etiology in Mechanically Ventilated Patients with Suspected Pneumonia
Strålin K, Ehn F, Giske Cg, Ullberg M, Hedlund J, Petersson J, et al
PloS one 2016;11(7):e0159694-

Bacterial Landscape of Bloodstream Infections in Neutropenic Patients via High Throughput Sequencing
Gyarmati P, Kjellander C, Aust C, Kalin M, Öhrmalm L, Giske Cg
PloS one 2015;10(8):e0135756-

[Beta lactam antibiotics and the question of dose regimen for severe infection. Prolonged infusion theoretically appealing--yet no evidence of clinical benefit]
Leander G, Eliasson E, Hanberger H, Giske C
Lakartidningen 2015;112():-

Carbapenemase-producing Enterobacteriaceae in Sweden 2007-2013: Experiences from seven years of systematic surveillance and mandatory reporting
Löfmark S, Sjöström K, Mäkitalo B, Edquist P, Tegmark Wisell K, Giske Cg
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2015;20():29-38

Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin
Giske Cg
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015;21(10):899-905

Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
Tängdén T, Giske Cg
Journal of internal medicine 2015;277(5):501-12

Knowledge and understanding of antibiotic resistance and the risk of becoming a carrier when travelling abroad: a qualitative study of Swedish travellers
Wiklund S, Fagerberg I, Örtqvist Å, Vading M, Giske Cg, Broliden K, et al
Scandinavian journal of public health 2015;43(3):302-8

Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10
Sturegård E, Ängeby Ka, Werngren J, Juréen P, Kronvall G, Giske Cg, et al
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015;21(2):148.e5-7

Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis
Davies Forsman L, Giske Cg, Bruchfeld J, Schön T, Juréen P, Ängeby K
International journal of mycobacteriology 2015;4 Suppl 1():80-1

Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis
Davies Forsman L, Giske Cg, Bruchfeld J, Schön T, Juréen P, Ängeby K
Antimicrobial agents and chemotherapy 2015;59(6):3630-2

Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy - A 10-year population-based cohort study
Aly M, Dyrdak R, Nordström T, Jalal S, Weibull Ce, Giske Cg, et al
The Prostate 2015;75(9):947-56

[Response times can be shortened in microbiological diagnosis of sepsis. Better opening hours in laboratories and active advice enables faster therapy]
Åkerlund A, Sundqvist M, Hanberger H, Åhrén C, Serrander L, Giske Cg
Lakartidningen 2015;112():-

Reviving old antibiotics
Theuretzbacher U, Van Bambeke F, Cantón R, Giske Cg, Mouton Jw, Nation Rl, et al
The Journal of antimicrobial chemotherapy 2015;70(8):2177-81

Successful international clones of blaCTX-M-15-producing Klebsiella pneumoniae with coexpression of plasmid-mediated quinolone resistance (PMQR) determinants in Tehran hospitals
Nematzadeh S, Shahcheraghi F, Iversen A, Giske Cg
Diagnostic microbiology and infectious disease 2015;83(4):371-4

Surveillance of antimicrobial resistance among Escherichia coli in wastewater in Stockholm during 1 year: does it reflect the resistance trends in the society?
Kwak Yk, Colque P, Byfors S, Giske Cg, Möllby R, Kühn I
International journal of antimicrobial agents 2015;45(1):25-32

The aetiology of paediatric bloodstream infections changes after pneumococcal vaccination and group B streptococcus prophylaxis
Luthander J, Bennet R, Giske Cg, Nilsson A, Eriksson M
Acta paediatrica (Oslo, Norway : 1992) 2015;104(9):933-9

Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe
Brown D, Canton R, Dubreuil L, Gatermann S, Giske C, Macgowan A, et al
EUROSURVEILLANCE 2015;20(2):21-28

Antibiotic consumption and antibiotic stewardship in Swedish hospitals
Hanberger H, Skoog G, Ternhag A, Giske Cg
Upsala journal of medical sciences 2014;119(2):154-61

Dissemination of blaVIM in Greece at the peak of the epidemic of 2005-2006: clonal expansion of Klebsiella pneumoniae clonal complex 147
Hasan Cm, Turlej-rogacka A, Vatopoulos Ac, Giakkoupi P, Maâtallah M, Giske Cg
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2014;20(1):34-7

Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011
Brolund A, Edquist Pj, Mäkitalo B, Olsson-liljequist B, Söderblom T, Wisell Kt, et al
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2014;20(6):O344-52

Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments
Tängdén T, Hickman Ra, Forsberg P, Lagerbäck P, Giske Cg, Cars O
Antimicrobial agents and chemotherapy 2014;58(3):1757-62

Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors
Titelman E, Hasan Cm, Iversen A, Nauclér P, Kais M, Kalin M, et al
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2014;20(8):O508-15

Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis
Davies Forsman L, Schön T, Simonsson Us, Bruchfeld J, Larsson M, Juréen P, et al
Antimicrobial agents and chemotherapy 2014;58(12):7557-9

Klebsiella variicola is a frequent cause of bloodstream infection in the stockholm area, and associated with higher mortality compared to K. pneumoniae
Maatallah M, Vading M, Kabir Mh, Bakhrouf A, Kalin M, Nauclér P, et al
PloS one 2014;9(11):e113539-

Nuclease-assisted suppression of human DNA background in sepsis
Song Y, Giske Cg, Gille-johnson P, Emanuelsson O, Lundeberg J, Gyarmati P
PloS one 2014;9(7):e103610-

Occurrence of virulence genes, 16S rRNA methylases, and plasmid-mediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan
Habeeb Ma, Haque A, Iversen A, Giske Cg
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2014;33(3):399-409

Performance of the EUCAST Disk Diffusion Method, the CLSI Agar Screen Method, and the Vitek 2 Automated Antimicrobial Susceptibility Testing System for Detection of Clinical Isolates of Enterococci with Low- and Medium-Level VanB-Type Vancomycin Resistance: a Multicenter Study
Nordicast Vre Detection Study Gr, Hegstad K, Giske Cg, Haldorsen B, Matuschek E, Schonning K, et al
JOURNAL OF CLINICAL MICROBIOLOGY 2014;52(5):1582-9

Prevalence of community-acquired bacteraemia in Guinea-Bissau: an observational study
Isendahl J, Manjuba C, Rodrigues A, Xu W, Henriques-normark B, Giske Cg, et al
BMC infectious diseases 2014;14():3859-

Subnormal levels of vitamin D are associated with acute wheeze in young children
Stenberg Hammar K, Hedlin G, Konradsen Jr, Nordlund B, Kull I, Giske Cg, et al
Acta paediatrica (Oslo, Norway : 1992) 2014;103(8):856-61

The detection and verification of carbapenemases using ertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight
Johansson A, Ekelöf J, Giske Cg, Sundqvist M
BMC microbiology 2014;14():89-

Age and risk factors influence the microbial aetiology of bloodstream infection in children
Luthander J, Bennet R, Giske Cg, Nilsson A, Eriksson M
Acta paediatrica (Oslo, Norway : 1992) 2013;102(2):182-6

A multiresistant clone of Pseudomonas aeruginosa sequence type 773 spreading in a burn unit in Orumieh, Iran
Yousefi S, Nahaei Mr, Farajnia S, Aghazadeh M, Iversen A, Edquist P, et al
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013;121(2):146-52

Attachment and biofilm forming capabilities of Staphylococcus epidermidis strains isolated from preterm infants
Hell E, Giske Cg, Hultenby K, Danielsson Kg, Marchini G
Current microbiology 2013;67(6):712-7

Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patterns
Aust C, Tolfvenstam T, Broliden K, Ljungman P, Kalin M, Giske Cg, et al
Scandinavian journal of infectious diseases 2013;45(4):285-91

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013
European Survey, Glasner C, Albiger B, Buist G, Andrasevic At, Canton R, et al
EUROSURVEILLANCE 2013;18(28):-

[ESBL-CARBA can become a problem in Swedish health care]
Giske Cg, Kalin M
Lakartidningen 2013;110(32-33):1398-

EUCAST expert rules in antimicrobial susceptibility testing
Leclercq R, Canton R, Brown Dfj, Giske Cg, Heisig P, Macgowan Ap, et al
CLINICAL MICROBIOLOGY AND INFECTION 2013;19(2):141-60

Four genotyping schemes for phylogenetic analysis of Pseudomonas aeruginosa: comparison of their congruence with multi-locus sequence typing
Maâtallah M, Bakhrouf A, Habeeb Ma, Turlej-rogacka A, Iversen A, Pourcel C, et al
PloS one 2013;8(12):e82069-

High prevalence of 16S rRNA methylase RmtB among CTX-M extended-spectrum β-lactamase-producing Klebsiella pneumoniae from Islamabad, Pakistan
Habeeb Ma, Haque A, Nematzadeh S, Iversen A, Giske Cg
International journal of antimicrobial agents 2013;41(6):524-6

High proportion of intestinal colonization with successful epidemic clones of ESBL-producing Enterobacteriaceae in a neonatal intensive care unit in Ecuador
Nordberg V, Quizhpe Peralta A, Galindo T, Turlej-rogacka A, Iversen A, Giske Cg, et al
PloS one 2013;8(10):e76597-

Phenotypic detection of plasmid-acquired AmpC in Escherichia coli--evaluation of screening criteria and performance of two commercial methods for the phenotypic confirmation of AmpC production
Edquist P, Ringman M, Liljequist Bo, Wisell Kt, Giske Cg
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2013;32(9):1205-10

Rational use of aminoglycosides - author response
Hanberger H, Fredriksson M, Ternhag A, Giske Cg
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2013;45(8):655-6

Rational use of aminoglycosides-Review and recommendations by the Swedish Reference Group for Antibiotics (SRGA)
Srga, Hanberger H, Edlund C, Furebring M, Giske Cg, Melhus A, et al
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2013;45(3):161-75

Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schön T, Juréen P, Chryssanthou E, Giske Cg, Kahlmeter G, Hoffner S, et al
The Journal of antimicrobial chemotherapy 2013;68(9):2074-7

The relative importance of Staphylococcus saprophyticus as a urinary tract pathogen: distribution of bacteria among urinary samples analysed during 1 year at a major Swedish laboratory
Eriksson A, Giske Cg, Ternhag A
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013;121(1):72-8

Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae (vol 82, pg 229, 2010)
Brolund A, Wisell Kt, Edquist Pj, Elfstrom L, Walder M, Giske Cg
JOURNAL OF MICROBIOLOGICAL METHODS 2012;88(1):188-188

Diverse Sequence Types of Klebsiella pneumoniae Contribute to the Dissemination of bla(NDM-1) in India, Sweden, and the United Kingdom
Giske Cg, Froding I, Hasan Cm, Turlej-rogacka A, Toleman M, Livermore D, et al
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2012;56(5):2735-8

Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
Titelman E, Iversen A, Kalin M, Giske Cg
MICROBIAL DRUG RESISTANCE 2012;18(2):189-92

Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL-, AmpC- and carbapenemase-producing Enterobacteriaceae
Hansen F, Hammerum Am, Skov Rl, Giske Cg, Sundsfjord A, Samuelsen O
APMIS 2012;120(9):724-32

Fecal carriage of ESBL-producing E. coli and K. pneumoniae in children in Guinea-Bissau: a hospital-based cross-sectional study
Isendahl J, Turlej-rogacka A, Manjuba C, Rodrigues A, Giske Cg, Nauclér P
PloS one 2012;7(12):e51981-

First outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting
Rettedal S, Lohr Ih, Natas O, Giske Cg, Sundsfjord A, Oymar K
APMIS 2012;120(8):612-21

Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study
Kjellander C, Bjorkholm M, Cherif H, Kalin M, Giske Cg
EUROPEAN JOURNAL OF HAEMATOLOGY 2012;88(5):422-30

Identification and screening of carbapenemase-producing Enterobacteriaceae
European Network Carbapenemases, Nordmann P, Gniadkowski M, Giske Cg, Poirel L, Woodford N, et al
CLINICAL MICROBIOLOGY AND INFECTION 2012;18(5):432-8

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
Magiorakos Ap, Srinivasan A, Carey Rb, Carmeli Y, Falagas Me, Giske Cg, et al
CLINICAL MICROBIOLOGY AND INFECTION 2012;18(3):268-81

Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention
Andersson H, Lindholm C, Iversen A, Giske Cg, Örtqvist Å, Kalin M, et al
Scandinavian journal of infectious diseases 2012;44(9):641-9

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
European Network Carbapenemases, Canton R, Akova M, Carmeli Y, Giske Cg, Glupczynski Y, et al
CLINICAL MICROBIOLOGY AND INFECTION 2012;18(5):413-31

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
Mouton Jw, Brown Dfj, Apfalter P, Canton R, Giske Cg, Ivanova M, et al
CLINICAL MICROBIOLOGY AND INFECTION 2012;18(3):E37-45

A Diversity of OXA-Carbapenemases and Class 1 Integrons Among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Sweden Belonging to Different International Clonal Lineages
Karah N, Giske Cg, Sundsfjord A, Samuelsen O
MICROBIAL DRUG RESISTANCE 2011;17(4):545-9

Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
Titelman E, Iversen A, Kahlmeter G, Giske Cg
APMIS 2011;119(12):853-63

A sensitive and specific phenotypic assay for detection of metallo-beta-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin
Giske Cg, Gezelius L, Samuelsen O, Warner M, Sundsfjord A, Woodford N
CLINICAL MICROBIOLOGY AND INFECTION 2011;17(4):552-6

Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems
Vading M, Samuelsen O, Haldorsen B, Sundsfjord As, Giske Cg
CLINICAL MICROBIOLOGY AND INFECTION 2011;17(5):668-74

Epidemiology and characteristics of antimicrobial resistance in China
Xiao Yh, Giske Cg, Wei Zq, Shen P, Heddini A, Li Lj
DRUG RESISTANCE UPDATES 2011;14(4-5):236-50

In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14-and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
Titelman E, Karlsson Im, Ge Yg, Giske Cg
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 2011;70(1):137-41

Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance
Samuelsen O, Toleman Ma, Hasseltvedt V, Fuursted K, Leegaard Tm, Walsh Tr, et al
CLINICAL MICROBIOLOGY AND INFECTION 2011;17(12):1811-6

Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235
Maatallah M, Cheriaa J, Backhrouf A, Iversen A, Grundmann H, Do T, et al
PLOS ONE 2011;6(10):e25617-

Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion
Kronvall G, Giske Cg, Kahlmeter G
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2011;38(4):281-90

When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock
Hanberger H, Giske Cg, Giamarellou H
Current infectious disease reports 2011;13(5):416-25

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis
Schon T, Jureen P, Chryssanthou E, Giske Cg, Sturegard E, Kahlmeter G, et al
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE 2011;15(4):502-9

Wild-Type MIC Distributions Must Be Considered To Set Clinically Meaningful Susceptibility Testing Breakpoints for All Bacterial Pathogens, Including Mycobacterium tuberculosis
Angeby K, Giske Cg, Jureen P, Schon T
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2011;55(9):4492-3

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske Cg, Gniadkowski M, et al
CLINICAL MICROBIOLOGY AND INFECTION 2010;16(2):112-22

Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts
Cnse Working Grp, Grundmann H, Livermore Dm, Giske Cg, Canton R, Rossolini Gm, et al
EUROSURVEILLANCE 2010;15(46):22-34

Detecting Carbapenemase Producers in the Clinic
Giske C
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2010;:E179-E179

Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae
Brolund A, Wisell Kt, Edquist Pj, Elfstrom L, Walder M, Giske Cg
JOURNAL OF MICROBIOLOGICAL METHODS 2010;82(3):229-33

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Kumarasamy Kk, Toleman Ma, Walsh Tr, Bagaria J, Butt F, Balakrishnan R, et al
LANCET INFECTIOUS DISEASES 2010;10(9):597-602

Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods
Johansson N, Kalin M, Tiveljung-lindell A, Giske Cg, Hedlund J
CLINICAL INFECTIOUS DISEASES 2010;50(2):202-9

Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis
Hell E, Giske Cg, Nelson A, Romling U, Marchini G
LETTERS IN APPLIED MICROBIOLOGY 2010;50(2):211-5

Molecular Epidemiology of Metallo-beta-Lactamase-Producing Pseudomonas aeruginosa Isolates from Norway and Sweden Shows Import of International Clones and Local Clonal Expansion
Samuelsen O, Toleman Ma, Sundsfjord A, Rydberg J, Leegaard Tm, Walder M, et al
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2010;54(1):346-52

[More severe bacterial infections could be prevented with vaccine. Rotavirus, influenza and varicella cause thousands of hospital admissions]
Bennet R, Bogdanovic G, Giske Cg, Eriksson M
Lakartidningen 2010;107(48):3040-3

[New guidelines for vancomycin in staphylococcal infections]
Giske Cg, Odenholt I, Kahlmeter G
Lakartidningen 2010;107(11):742-

Outbreak of CTX-M-15-producing Klebsiella pneumoniae of sequence type 199 in a Latvian teaching hospital
Dumpis U, Iversen A, Balode A, Saule M, Miklasevics E, Giske Cg
APMIS 2010;118(9):713-6

[Penicillin V and how three dosages became two and than three again. History behind treatment of otitis, sinusitis and pharyngo-tonsillitis]
Giske Cg, Eriksson M, Hermansson A, Kumlien J, Odenholt I, Cars O
Lakartidningen 2010;107(40):2392-5

Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future
Esgars, Giske Cg, Cornaglia G
DRUG RESISTANCE UPDATES 2010;13(4-5):93-8

The DiversiLab system versus pulsed-field gel electrophoresis: Characterisation of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae
Brolund A, Haeggman S, Edquist Pj, Gezelius L, Olsson-liljequist B, Wisell Kt, et al
JOURNAL OF MICROBIOLOGICAL METHODS 2010;83(2):224-30

Transthoracic fine-needle aspiration in the aetiological diagnosis of community-acquired pneumonia
Hernes Ss, Hagen E, Tofteland S, Finsen Nt, Christensen A, Giske Cg, et al
CLINICAL MICROBIOLOGY AND INFECTION 2010;16(7):909-11

Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections
Jureen P, Angeby K, Sturegard E, Chryssanthou E, Giske Cg, Werngren J, et al
JOURNAL OF CLINICAL MICROBIOLOGY 2010;48(5):1853-8

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
Angeby Ka, Jureen P, Giske Cg, Chryssanthou E, Sturegard E, Nordvall M, et al
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2010;65(5):946-52

Activity of cephalosporin CXA-101 (FR264205) and comparators against extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa
Giske Cg, Ge J, Nordmann P
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2009;64(2):430-1

Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Yong D, Toleman Ma, Giske Cg, Cho Hs, Sundman K, Lee K, et al
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2009;53(12):5046-54

Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden
Samuelsen O, Naseer U, Tofteland S, Skutlaberg Dh, Onken A, Hjetland R, et al
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2009;63(4):654-8

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis
Schon T, Jureen P, Giske Cg, Chryssanthou E, Sturegard E, Werngren J, et al
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2009;64(4):786-93

Interplay of Efflux, Impermeability, and AmpC Activity Contributes to Cefuroxime Resistance in Clinical, Non-ESBL-Producing Isolates of Escherichia coli
Kallman O, Giske Cg, Samuelsen O, Wretlind B, Kalin M, Olsson-liljequist B
MICROBIAL DRUG RESISTANCE 2009;15(2):91-5

Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
Kitchel B, Rasheed Jk, Patel Jb, Srinivasan A, Navon-venezia S, Carmeli Y, et al
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2009;53(8):3365-70

[Quantitative lower respiratory tract cultures and how to interpret them. Infection must be discriminated from colonization]
Petersson J, Kalin M, Giske Cg
Lakartidningen 2009;106(34):2052-6

Redefining extended-spectrum beta-lactamases: balancing science and clinical need
Giske Cg, Sundsfjord As, Kahlmeter G, Woodford N, Nordmann P, Paterson Dl, et al
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2009;63(1):1-4

Redefining extended-spectrum beta-lactamases: balancing science and clinical need-authors' response
Giske Cg, Sundsfjord As, Kahlmeter G, Woodford N, Nordmann P, Paterson Dl, et al
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2009;64(1):213-215

Staphylococcus epidermidis Isolated From Newborn Infants Express Pilus-Like Structures and Are Inhibited by the Cathelicidin-Derived Antimicrobial Peptide LL37
Nelson A, Hultenby K, Hell E, Riedel Hm, Brismar H, Flock Ji, et al
PEDIATRIC RESEARCH 2009;66(2):174-8

The First Metallo-beta-Lactamase Identified in Norway Is Associated with a TniC-Like Transposon in a Pseudomonas aeruginosa Isolate of Sequence Type 233 Imported from Ghana
Samuelsen O, Buaro L, Toleman Ma, Giske Cg, Hermansen No, Walsh Tr, et al
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2009;53(1):331-2

["The wolf" is already here. Recent data in Stockholm shows increasing antibiotic resistance]
Kronvall G, Giske Cg
Lakartidningen 2009;106(47):3160-1

Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa
Giske Cg, Buaro L, Sundsfjord A, Wretlind B
MICROBIAL DRUG RESISTANCE 2008;14(1):23-30

Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs
Erlandsson M, Gill H, Nordlinder D, Giske Cg, Jonas D, Nilsson Le, et al
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2008;40(6-7):487-94

Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels
Kallman O, Motakefi A, Wretlind B, Kalin M, Olsson-liljequist B, Giske Cg
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2008;62(5):986-90

Clinical and economic impact of common multidrug-resistant gram-negative bacilli
React-act Antibiot Resistance, Giske Cg, Monnet Dl, Cars O, Carmeli Y
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2008;52(3):813-21

Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country
Samuelsen O, Buaro L, Giske Cg, Simonsen Gs, Aasnaes B, Sundsfjord A
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2008;61(4):827-30

Identification of the first VIM metallo-beta-lactamase-producing multiresistant Aeromonas hydrophila strain
Libisch B, Giske Cg, Kovacs B, Toth Tg, Fuzi M
JOURNAL OF CLINICAL MICROBIOLOGY 2008;46(5):1878-80

Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia
Johansson N, Kalin M, Giske Cg, Hedlund J
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 2008;60(3):255-61

Staphylococcus epidermidis isolated from newborn infants express pilus structures
Nelson A, Hultenby K, Riedel H, Giske C, Motakefi A, Marchini G
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2008;68(2):246-247

Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue
Wisell Kt, Kahlmeter G, Giske Cg
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2008;62(1):35-40

[Invasive pneumococcal infection can cause meningitis in children. Uncertainty about the mass protective effect of the vaccine from USA]
Eriksson M, Bennet R, Fuhrmann D, Giske Cg, Rylander M
Lakartidningen 2007;104(24-25):1906-1908

Establishing clonal relationships between VIM-1-like metallo-beta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing
Giske Cg, Libisch B, Colinon C, Scoulica E, Pagani L, Fuzi M, et al
JOURNAL OF CLINICAL MICROBIOLOGY 2006;44(12):4309-15

[Nosocomial infections with multiresistant bacteria--not only staphylococci]
Petersson J, Giske Cg, Aufwerber E, Jörbeck H
Lakartidningen 2006;103(35):2478-81

Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR
Kais M, Spindler C, Kalin M, Ouml, Rtqvist A, Giske Cg
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 2006;55(3):169-78

[Quinolones should not be administered in monotherapy for Pseudomonas aeruginosa infection]
Giske Cg, Wretlind B
Lakartidningen 2006;103(14):1121-2

Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates
El Amin N, Giske Cg, Jalal S, Keijser B, Kronvall G, Wretlind B
APMIS 2005;113(3):187-96

Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA
Giske Cg, Boren C, Wretlind B, Kronvall G
CLINICAL MICROBIOLOGY AND INFECTION 2005;11(8):662-9

VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden
Giske Cg, Rylander M, Kronvall G
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2003;47(9):3034-5

Show all publications